Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.10
Bid: 40.72
Ask: 40.80
Change: -0.24 (-0.58%)
Spread: 0.08 (0.196%)
Open: 41.36
High: 41.40
Low: 40.40
Prev. Close: 41.34
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

8 Apr 2024 16:34

RNS Number : 7362J
Assura PLC
08 April 2024
 

8 April 2024

Assura plc

("the Company")

Notifications of transactions by Persons Discharging Managerial Responsibilities ("PDMRs")

The Company announces that on 5 April 2024 the following named PDMRs acquired partnership shares and were awarded matching share awards over ordinary shares of 10 pence each in the Company under the Company's Share Incentive Plan ("SIP").

PDMR

Position

Number of partnership shares acquired

Number of matching shares awarded

Shareholding of PDMR and PCAs post acquisition and award

Jonathan Murphy

CEO

363

423

2,947,592

Jayne Cottam

CFO

363

423

710,028

Orla Ball

General Counsel

363

423

27,041

Robert James

Interim CIO

363

423

18,541

Sarah Taylor

Chief People Officer

363

423

8,128

The Notification of Dealing Form for each PDMR can be found below.

This notification is made in accordance with the Market Abuse Regulation.

 

Notification of dealing form

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Jonathan Murphy

2

Reason for the notification

 

a)

Position/status

 

CEO

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

 

Acquisition of partnership shares and award of matching shares under the SIP

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£0.4131 GBP

 

 

786

 

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£0.4131 GBP

 

 

786

 

£324.70 GBP

e)

Date of the transaction

 

5 April 2024

f)

Place of the transaction

 

XLON

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Jayne Cottam

2

Reason for the notification

 

a)

Position/status

 

CFO

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

 

Acquisition of partnership shares and award of matching shares under the SIP

 

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£0.4131 GBP

 

 

786

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£0.4131 GBP

 

 

786

 

£324.70 GBP

e)

Date of the transaction

 

5 April 2024

f)

Place of the transaction

 

XLON

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Orla Ball

2

Reason for the notification

 

a)

Position/status

 

General Counsel

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

 

Acquisition of partnership shares and award of matching shares under the SIP

 

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£0.4131 GBP

 

 

786

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£0.4131 GBP

 

 

786

 

£324.70 GBP

e)

Date of the transaction

 

5 April 2024

f)

Place of the transaction

 

XLON

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Robert James

2

Reason for the notification

 

a)

Position/status

 

Interim CIO

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

 

Acquisition of partnership shares and award of matching shares under the SIP

 

 

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£0.4131 GBP

 

 

786

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£0.4131 GBP

 

 

786

 

£324.70 GBP

e)

Date of the transaction

 

5 April 2024

f)

Place of the transaction

 

XLON

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Sarah Taylor

2

Reason for the notification

 

a)

Position/status

 

Chief People Officer

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

 

Acquisition of partnership shares and award of matching shares under the SIP

 

 

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£0.4131 GBP

 

 

786

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£0.4131 GBP

 

 

786

 

£324.70 GBP

e)

Date of the transaction

 

5 April 2024

f)

Place of the transaction

 

XLON

 

 

For more information, please contact:

 

Assura plc

 

Tel: 0161 515 2043

Orla Ball, General Counsel

David Purcell, Investor Relations Director

 

Email: Investor@assura.co.uk

FGS Global

Gordon Simpson

Tel: 0207 251 3801

Email: Assura@fgsglobal.com

 

Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served.

A constituent of the FTSE 250 and the EPRA* indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion.

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026. 

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association Assura plc LEI code: 21380026T19N2Y52XF72

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBUGDSDXGDGSI
Date   Source Headline
13th Jun 20147:00 amRNSAcquisition of 28 medical centres for £107 million
10th Jun 20149:44 amRNSConfirmation of Quarterly Interim Dividend
23rd May 20147:00 amRNSPreliminary results for year ended 31 March 2014
2nd Apr 201411:42 amRNSConfirmation of Quarterly Interim Dividend
4th Mar 201412:00 pmRNSDirector/PDMR Shareholding
14th Feb 20147:00 amRNSInterim Management Statement
13th Feb 201411:58 amRNSNotification of Major Interest in Shares
11th Feb 20144:48 pmRNSNotification of Major Interest in Shares
29th Jan 20144:39 pmRNSNotification of Vesting of Share Award to PDMR
24th Jan 201410:17 amRNSDirector/PDMR Shareholding
24th Jan 20147:00 amRNSSale of LIFT Investments
2nd Jan 20144:15 pmRNSDirector/PDMR Shareholding
20th Dec 201310:46 amRNSConfirmation of Quarterly Interim Dividend
12th Dec 20131:17 pmRNSNotification of major interest in shares
11th Dec 20133:23 pmRNSNotification of major interest in shares
10th Dec 20133:45 pmRNSNotification of major interest in shares
9th Dec 20133:52 pmRNSNotification of major interest in shares
9th Dec 20133:01 pmRNSNotification of major interest in shares
3rd Dec 20134:22 pmRNSDirector/PDMR Shareholding
3rd Dec 201310:18 amRNSNotification of major interest in shares
27th Nov 20131:03 pmRNSDirector/PDMR Shareholding
27th Nov 20131:01 pmRNSDirector/PDMR Shareholding
26th Nov 20137:00 amRNSInterim Results 2013
25th Nov 20137:00 amRNSSale of LIFT Investments
5th Nov 20133:43 pmRNSDirector Declaration
5th Nov 20131:23 pmRNSNotification of Major Interests in Shares
14th Oct 20131:31 pmRNSNotifications of Major Interests in Shares
3rd Oct 20137:00 amRNSConfirmation of Quarterly Interim Dividend
19th Sep 20131:33 pmRNSResults of AGM
11th Sep 20137:00 amRNSAcquisition of 32 medical centres for £62.5m
20th Aug 20134:35 pmRNSHolding(s) in Company
16th Aug 20137:00 amRNSAppointment of Joint Corporate Broker
12th Aug 20137:00 amRNSInterim Management Statement
24th Jul 201310:25 amRNSAnnual Information Update
22nd Jul 20134:04 pmRNSAnnual Report 2013
17th Jun 201310:05 amRNSConfirmation of Quarterly Interim Dividend
29th May 201311:42 amRNSForm 8.5 (EPT/NON-RI)
29th May 201310:54 amRNSForm 8.5 (EPT/NON-RI)
29th May 20139:46 amRNSForm 8.5 (EPT/NON-RI)
29th May 20139:38 amRNSForm 8.5 (EPT/RI)
28th May 20135:15 pmRNSOffer Update
28th May 20131:51 pmRNSForm 8.3 - Assura Group Ltd
28th May 201312:27 pmRNSRejection of MedicX Proposal
28th May 201312:26 pmRNSUnaudited Preliminary Results to 31 March 2013
28th May 201311:04 amRNSForm 8.5 (EPT/NON-RI)
28th May 201310:04 amRNSForm 8.5 (EPT/NON-RI)
28th May 20137:54 amRNSForm 8.5 (EPT/RI)
24th May 20139:31 amRNSForm 8.5 (EPT/NON-RI)
24th May 20138:48 amRNSForm 8.5 (EPT/NON-RI)
24th May 20138:11 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.